Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001013762-13-000367
Filing Date
2013-03-07
Accepted
2013-03-07 12:42:43
Documents
1
Effectiveness Date
2013-03-07
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11726
  Complete submission text file 0001013762-13-000367.txt   12938
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-191549 | Film No.: 13672445
SIC: 2834 Pharmaceutical Preparations